{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:40:58Z","timestamp":1792003258665,"version":"4.4.0"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"am","delay-in-days":260,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.semcdb.2023.10.007","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T05:49:59Z","timestamp":1700113799000},"page":"11-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Immunogenic cell stress and death in the treatment of cancer"],"prefix":"10.1016","volume":"156","author":[{"given":"Hui","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-9558","authenticated-orcid":false,"given":"Oliver","family":"Kepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib2","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.immuni.2018.06.003","article-title":"Immune checkpoint blockade across the cancer care continuum","volume":"48","author":"Helmink","year":"2018","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib4","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI35180","article-title":"The anticancer immune response: indispensable for therapeutic success?","volume":"118","author":"Zitvogel","year":"2008","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib5","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41591-023-02336-1","article-title":"Neoadjuvant immunotherapy for melanoma is now ready for clinical practice","volume":"29","author":"Garbe","year":"2023","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib6","doi-asserted-by":"crossref","first-page":"1996686","DOI":"10.1080\/2162402X.2021.1996686","article-title":"Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade","volume":"10","author":"Kroemer","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2023.10.007_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijms20040959","article-title":"Realizing the clinical potential of immunogenic cell death in cancer chemotherapy and radiotherapy","volume":"20","author":"Rapoport","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nri2545","article-title":"Immunogenic and tolerogenic cell death","volume":"9","author":"Green","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib9","doi-asserted-by":"crossref","first-page":"2219591","DOI":"10.1080\/2162402X.2023.2219591","article-title":"Trial watch: chemotherapy-induced immunogenic cell death in oncology","volume":"12","author":"Sprooten","year":"2023","journal-title":"Oncoimmunology"},{"issue":"7","key":"10.1016\/j.semcdb.2023.10.007_bib10","doi-asserted-by":"crossref","first-page":"1596652","DOI":"10.1080\/2162402X.2019.1596652","article-title":"Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death","volume":"8","author":"Liu","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2023.10.007_bib11","doi-asserted-by":"crossref","unstructured":"Liu P., Zhao L., Pol J., Levesque S., Petrazzuolo A., Pfirschke C., Engblom C., Rickelt S. Crizotinib-induced immunogenic cell death in non-small cell lung cancer. 2019;10(1):1486.","DOI":"10.1038\/s41467-019-09415-3"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib12","doi-asserted-by":"crossref","first-page":"1973197","DOI":"10.1080\/2162402X.2021.1973197","article-title":"Crizotinib and ceritinib trigger immunogenic cell death via on-target effects","volume":"10","author":"Petrazzuolo","year":"2021","journal-title":"Oncoimmunology"},{"issue":"328","key":"10.1016\/j.semcdb.2023.10.007_bib13","doi-asserted-by":"crossref","first-page":"328ra27","DOI":"10.1126\/scitranslmed.aae0105","article-title":"Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma","volume":"8","author":"Garg","year":"2016","journal-title":"Sci. Transl. Med"},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4049\/jimmunol.1701021","article-title":"Critical interactions between immunogenic cancer cell death, oncolytic viruses, and the immune system define the rational design of combination immunotherapies","volume":"200","author":"van Vloten","year":"2018","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.semcdb.2023.10.007_bib15","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.955691","article-title":"Consensus guidelines for the detection of immunogenic cell death","volume":"3","author":"Kepp","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2023.10.007_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcp.2018.02.006","article-title":"Stress-induced cellular responses in immunogenic cell death: implications for cancer immunotherapy","volume":"153","author":"Radogna","year":"2018","journal-title":"Biochem Pharm."},{"issue":"46","key":"10.1016\/j.semcdb.2023.10.007_bib17","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: a double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/2159-8290.CD-20-0465","article-title":"A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency","volume":"11","author":"Le Naour","year":"2021","journal-title":"Cancer Discov."},{"issue":"6263","key":"10.1016\/j.semcdb.2023.10.007_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.aad0779","article-title":"Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1","volume":"350","author":"Vacchelli","year":"2015","journal-title":"Science"},{"issue":"6062","key":"10.1016\/j.semcdb.2023.10.007_bib20","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib21","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ccell.2023.04.015","article-title":"Calreticulin exposure orchestrates innate immunosurveillance","volume":"41","author":"Guilbaud","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib23","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.4049\/jimmunol.152.11.5398","article-title":"Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70","volume":"152","author":"Udono","year":"1994","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib24","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1182\/blood-2006-10-054221","article-title":"Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications","volume":"109","author":"Spisek","year":"2007","journal-title":"Blood"},{"issue":"6894","key":"10.1016\/j.semcdb.2023.10.007_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.semcdb.2023.10.007_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib27","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Sistigu","year":"2014","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.semcdb.2023.10.007_bib28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2013.03.003","article-title":"Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells","volume":"38","author":"Ma","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.semcdb.2023.10.007_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.mcb.2021.12.028","article-title":"Assessment of type I interferon responses as a feature of immunogenic cell death","volume":"172","author":"Forveille","year":"2022","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.semcdb.2023.10.007_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/cells11223672","article-title":"Tumor immunogenic cell death as a mediator of intratumor CD8 T-cell recruitment","volume":"11","author":"Roussot","year":"2022","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.semcdb.2023.10.007_bib31","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41590-020-0751-0","article-title":"Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy","volume":"21","author":"Yamazaki","year":"2020","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1431086","article-title":"TFAM is a novel mediator of immunogenic cancer cell death","volume":"7","author":"Yang","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib33","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1038\/s41467-020-19970-9","article-title":"Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death","volume":"11","author":"Hayashi","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12601","article-title":"High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair","volume":"280","author":"Bianchi","year":"2017","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.semcdb.2023.10.007_bib35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.it.2007.08.004","article-title":"Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox","volume":"28","author":"Rubartelli","year":"2007","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.cdd.4402269","article-title":"Molecular characteristics of immunogenic cancer cell death","volume":"15","author":"Tesniere","year":"2008","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/sj.cdd.4402275","article-title":"Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin","volume":"15","author":"Tufi","year":"2008","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.semcdb.2023.10.007_bib38","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/cdd.2008.67","article-title":"The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death","volume":"15","author":"Panaretakis","year":"2008","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/emboj.2009.1","article-title":"Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death","volume":"28","author":"Panaretakis","year":"2009","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12967-023-04017-6","article-title":"Immunogenic cell death in cancer: concept and therapeutic implications","volume":"21","author":"Galluzzi","year":"2023","journal-title":"J. Transl. Med"},{"issue":"6671","key":"10.1016\/j.semcdb.2023.10.007_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib42","doi-asserted-by":"crossref","first-page":"2174723","DOI":"10.1080\/2162402X.2023.2174723","article-title":"Arsenic trioxide as an inducer of immunogenic cell death","volume":"12","author":"Kepp","year":"2023","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1149673","article-title":"Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy","volume":"5","author":"Yang","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2023.10.007_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121167","article-title":"Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate","volume":"278","author":"Lu","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib45","doi-asserted-by":"crossref","first-page":"2127273","DOI":"10.1080\/2162402X.2022.2127273","article-title":"Is ferroptosis immunogenic? The devil is in the details!","volume":"11","author":"Kepp","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2023.10.007_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-023-00623-w","article-title":"Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death","author":"Clucas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","article-title":"Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity","volume":"13","author":"Marin","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib48","doi-asserted-by":"crossref","first-page":"1862949","DOI":"10.1080\/2162402X.2020.1862949","article-title":"Ferroptosis becomes immunogenic: implications for anticancer treatments","volume":"10","author":"Tang","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2023.10.007_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jitc-2020-001369","article-title":"Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity","volume":"8","author":"Efimova","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib50","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/15548627.2017.1386359","article-title":"Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance","volume":"14","author":"Lin","year":"2018","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.celrep.2016.03.037","article-title":"Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity","volume":"15","author":"Aaes","year":"2016","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.semcdb.2023.10.007_bib52","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.semcdb.2023.10.007_bib53","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1158\/1078-0432.CCR-09-2891","article-title":"Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway","volume":"16","author":"Zitvogel","year":"2010","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2017.12.015","article-title":"Glutamate Dehydrogenase to the Rescue","volume":"69","author":"Coloff","year":"2018","journal-title":"Mol. Cell"},{"issue":"50","key":"10.1016\/j.semcdb.2023.10.007_bib55","doi-asserted-by":"crossref","first-page":"33741","DOI":"10.1074\/jbc.273.50.33741","article-title":"Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors","volume":"273","author":"Yoshida","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib56","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/emboj.2011.497","article-title":"A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death","volume":"31","author":"Garg","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.semcdb.2023.10.007_bib57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcancer.2015.02.004","article-title":"eIF2alpha phosphorylation as a biomarker of immunogenic cell death","volume":"33","author":"Kepp","year":"2015","journal-title":"Semin Cancer Biol."},{"issue":"29","key":"10.1016\/j.semcdb.2023.10.007_bib58","doi-asserted-by":"crossref","first-page":"26841","DOI":"10.18632\/oncotarget.4754","article-title":"Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal","volume":"6","author":"Garg","year":"2015","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib59","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1080\/10428194.2019.1599110","article-title":"Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML","volume":"60","author":"Aurelius","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1073\/pnas.012485299","article-title":"Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway","volume":"99","author":"Talloczy","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41419-020-2642-6","article-title":"Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) in autophagy","volume":"11","author":"Humeau","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib62","doi-asserted-by":"crossref","first-page":"1776570","DOI":"10.1080\/23723556.2020.1776570","article-title":"EIF2alpha phosphorylation: a hallmark of both autophagy and immunogenic cell death","volume":"7","author":"Humeau","year":"2020","journal-title":"Mol. Cell Oncol."},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib63","article-title":"Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress","volume":"12","author":"Humeau","year":"2020"},{"issue":"12","key":"10.1016\/j.semcdb.2023.10.007_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2010.82","article-title":"Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia","volume":"1","author":"Wemeau","year":"2010","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib65","doi-asserted-by":"crossref","first-page":"2104551","DOI":"10.1080\/2162402X.2022.2104551","article-title":"Schweinfurthin induces ICD without ER stress and caspase activation","volume":"11","author":"Zhang","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2023.10.007_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.11.006","article-title":"Endoplasmic reticulum stress in the cellular release of damage-associated molecular patterns","volume":"350","author":"Wu Chuang","year":"2020","journal-title":"Int Rev. Cell Mol. Biol."},{"issue":"12","key":"10.1016\/j.semcdb.2023.10.007_bib67","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J. Exp. Med"},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib68","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1158\/2326-6066.CIR-19-0616","article-title":"Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4\/IKK2\/SNARE-dependent exocytosis","volume":"8","author":"Lau","year":"2020","journal-title":"Cancer Immunol. Res"},{"issue":"6102","key":"10.1016\/j.semcdb.2023.10.007_bib69","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1126\/science.1224922","article-title":"An immunosurveillance mechanism controls cancer cell ploidy","volume":"337","author":"Senovilla","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib70","doi-asserted-by":"crossref","first-page":"1721810","DOI":"10.1080\/2162402X.2020.1721810","article-title":"PT-112 induces immunogenic cell death and synergizes with immune checkpoint blockers in mouse tumor models","volume":"9","author":"Yamazaki","year":"2020","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib71","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1158\/2643-3230.BCD-21-0047","article-title":"Bortezomib induces anti-multiple myeloma immune response mediated by cGAS\/STING pathway activation","volume":"2","author":"Gulla","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/2643-3230.BCD-21-0059","article-title":"Bortezomib induces immunogenic cell death in multiple myeloma","volume":"2","author":"Zitvogel","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"143","key":"10.1016\/j.semcdb.2023.10.007_bib73","doi-asserted-by":"crossref","first-page":"143ra99","DOI":"10.1126\/scitranslmed.3003807","article-title":"Cardiac glycosides exert anticancer effects by inducing immunogenic cell death","volume":"4","author":"Menger","year":"2012","journal-title":"Sci. Transl. Med"},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib74","doi-asserted-by":"crossref","first-page":"1606665","DOI":"10.1080\/2162402X.2019.1606665","article-title":"A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers","volume":"8","author":"Kepp","year":"2019","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.semcdb.2023.10.007_bib75","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41419-021-03605-y","article-title":"a cardiac glycoside, induces immunogenic cell death via the PERK\/elF2alpha\/ATF4\/CHOP pathway in breast cancer","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcdb.2023.10.007_bib76","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28473","article-title":"Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set","volume":"3","author":"Sukkurwala","year":"2014","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib77","doi-asserted-by":"crossref","first-page":"15586","DOI":"10.1038\/s41598-022-19597-4","article-title":"The marine natural product mimic MPM-1 is cytolytic and induces DAMP release from human cancer cell lines","volume":"12","author":"von Hofsten","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcdb.2023.10.007_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202300347","article-title":"Local drug delivery techniques for triggering immunogenic cell death","author":"Ren","year":"2023","journal-title":"Small Methods"},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib79","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1021\/acsbiomaterials.2c00171","article-title":"PAMAM dendritic nanoparticle-incorporated hydrogel to enhance the immunogenic cell death and immune response of immunochemotherapy","volume":"8","author":"Hanurry","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"10","key":"10.1016\/j.semcdb.2023.10.007_bib80","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.7150\/thno.69168","article-title":"Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives","volume":"12","author":"Roemhild","year":"2022","journal-title":"Theranostics"},{"issue":"19","key":"10.1016\/j.semcdb.2023.10.007_bib81","doi-asserted-by":"crossref","first-page":"9470","DOI":"10.7150\/thno.62984","article-title":"Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem","volume":"11","author":"Ren","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib82","doi-asserted-by":"crossref","first-page":"1962592","DOI":"10.1080\/2162402X.2021.1962592","article-title":"LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells","volume":"10","author":"Yamazaki","year":"2021","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib83","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.trecan.2020.12.012","article-title":"Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides","volume":"7","author":"Vitale","year":"2021","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib84","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1038\/s41598-021-86239-6","article-title":"Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer","volume":"11","author":"Fleten","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib85","doi-asserted-by":"crossref","first-page":"328","DOI":"10.15698\/cst2019.11.202","article-title":"LTX-315 - a promising novel antitumor peptide and immunotherapeutic agent","volume":"3","author":"Zweytick","year":"2019","journal-title":"Cell Stress"},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib86","doi-asserted-by":"crossref","first-page":"348","DOI":"10.15698\/cst2019.11.204","article-title":"LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects","volume":"3","author":"Liao","year":"2019","journal-title":"Cell Stress"},{"key":"10.1016\/j.semcdb.2023.10.007_bib87","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.omto.2019.05.002","article-title":"The novel oncolytic compound LTX-401 induces antitumor immune responses in experimental hepatocellular carcinoma","volume":"14","author":"Mauseth","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"issue":"7","key":"10.1016\/j.semcdb.2023.10.007_bib88","doi-asserted-by":"crossref","first-page":"1594555","DOI":"10.1080\/2162402X.2019.1594555","article-title":"Tumor lysis with LTX-401 creates anticancer immunity","volume":"8","author":"Xie","year":"2019","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib89","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41419-018-1127-3","article-title":"Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals","volume":"9","author":"Zhou","year":"2018","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib90","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1338236","article-title":"Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model","volume":"6","author":"Nestvold","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.semcdb.2023.10.007_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.47","article-title":"The oncolytic peptide LTX-315 triggers immunogenic cell death","volume":"7","author":"Zhou","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib92","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-019-0272-7","article-title":"Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies","volume":"17","author":"Kepp","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.semcdb.2023.10.007_bib93","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1128\/JVI.03688-13","article-title":"Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer","volume":"88","author":"Angelova","year":"2014","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib94","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1470-2045(19)30788-0","article-title":"Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study","volume":"21","author":"Lonial","year":"2020","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.semcdb.2023.10.007_bib95","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1158\/1535-7163.MCT-21-0035","article-title":"Belantamab mafodotin (GSK2857916) drives immunogenic cell death and immune-mediated antitumor responses in vivo","volume":"20","author":"Montes de Oca","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib96","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/bjh.12427","article-title":"The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab","volume":"162","author":"Cheadle","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.semcdb.2023.10.007_bib97","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.jid.2019.12.039","article-title":"Imiquimod exerts antitumor effects by inducing immunogenic cell death and is enhanced by the glycolytic inhibitor 2-deoxyglucose","volume":"140","author":"Huang","year":"2020","journal-title":"J. Invest Dermatol."},{"issue":"12","key":"10.1016\/j.semcdb.2023.10.007_bib98","doi-asserted-by":"crossref","first-page":"8333","DOI":"10.1021\/acsabm.1c00861","article-title":"Polypeptide-based K(+) ionophore as a strong immunogenic cell death inducer for cancer immunotherapy","volume":"4","author":"Lee","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"10","key":"10.1016\/j.semcdb.2023.10.007_bib99","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/sj.cdd.4402201","article-title":"Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis","volume":"14","author":"Obeid","year":"2007","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib100","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(19)30171-8","article-title":"Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy","volume":"20","author":"Deutsch","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcdb.2023.10.007_bib101","article-title":"Molecular determinants of immunogenic cell death elicited by radiation therapy","author":"Galassi","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.semcdb.2023.10.007_bib102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15252\/embj.201798354","article-title":"Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus","volume":"37","author":"Gomes-da-Silva","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.semcdb.2023.10.007_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14010196","article-title":"Induction of immunogenic cell death by photodynamic therapy mediated by aluminum-phthalocyanine in nanoemulsion","volume":"14","author":"Rodrigues","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib104","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1038\/s41598-021-86354-4","article-title":"ovel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death","volume":"11","author":"Turubanova","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib105","doi-asserted-by":"crossref","first-page":"9240","DOI":"10.1021\/acsnano.2c01669","article-title":"ER-targeting PDT converts tumors into in situ therapeutic tumor vaccines","volume":"16","author":"Liu","year":"2022","journal-title":"ACS Nano"},{"issue":"32","key":"10.1016\/j.semcdb.2023.10.007_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202300859","article-title":"Molecular engineering of NIR-II\/IIb emitting AIEgen for multimodal imaging-guided photo-immunotherapy","volume":"19","author":"Xu","year":"2023","journal-title":"Small"},{"issue":"15","key":"10.1016\/j.semcdb.2023.10.007_bib107","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1039\/D3BM00700F","article-title":"NIR-II imaging-guided photothermal cancer therapy combined with enhanced immunogenic death","volume":"11","author":"Wang","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.semcdb.2023.10.007_bib108","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.2147\/IJN.S408855","article-title":"Multifunctional nanoplatform-mediated chemo-photothermal therapy combines immunogenic cell death with checkpoint blockade to combat triple-negative breast cancer and distant metastasis","volume":"18","author":"Zhu","year":"2023","journal-title":"Int J. Nanomed."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib109","doi-asserted-by":"crossref","first-page":"2098658","DOI":"10.1080\/2162402X.2022.2098658","article-title":"A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapy","volume":"11","author":"Kepp","year":"2022","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.semcdb.2023.10.007_bib110","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s43018-020-00107-2","article-title":"Pseudovirus for immunotherapy","volume":"1","author":"Kepp","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.semcdb.2023.10.007_bib111","first-page":"11","article-title":"Immunogenic cell death in electroporation-based therapies depends on pulse waveform characteristics","author":"Polajzer","year":"2023","journal-title":"Vaccin. (Basel)"},{"issue":"28","key":"10.1016\/j.semcdb.2023.10.007_bib112","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1039\/D2TB01004F","article-title":"Magnetic hyperthermia induces effective and genuine immunogenic tumor cell death with respect to exogenous heating","volume":"10","author":"Yan","year":"2022","journal-title":"J. Mater. Chem. B."},{"issue":"3","key":"10.1016\/j.semcdb.2023.10.007_bib113","first-page":"3881","article-title":"Nitric oxide induces immunogenic cell death and potentiates cancer immunotherapy","volume":"16","author":"Jiang","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.semcdb.2023.10.007_bib114","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jitc-2021-004151","article-title":"Local anesthetics elicit immune-dependent anticancer effects","volume":"10","author":"Bezu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.semcdb.2023.10.007_bib115","doi-asserted-by":"crossref","first-page":"9053274","DOI":"10.1155\/2020\/9053274","article-title":"Cordyceps militaris induces immunogenic cell death and enhances antitumor immunogenic response in breast cancer","volume":"2020","author":"Quan","year":"2020","journal-title":"Evid. Based Complement Altern. Med"},{"issue":"30","key":"10.1016\/j.semcdb.2023.10.007_bib116","doi-asserted-by":"crossref","first-page":"29543","DOI":"10.18632\/oncotarget.4911","article-title":"Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression","volume":"6","author":"Granato","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib117","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41571-022-00717-y","article-title":"Thermal immuno-nanomedicine in cancer","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcdb.2023.10.007_bib118","first-page":"2","article-title":"Arginine deiminase induces immunogenic cell death and is enhanced by N-acetylcysteine in murine MC38 colorectal cancer cells and MDA-MB-231 human breast cancer cells in vitro","volume":"26","author":"Huang","year":"2021","journal-title":"Molecules"},{"issue":"26","key":"10.1016\/j.semcdb.2023.10.007_bib119","doi-asserted-by":"crossref","first-page":"eadf2746","DOI":"10.1126\/sciadv.adf2746","article-title":"A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response","volume":"9","author":"Kar","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcdb.2023.10.007_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122278","article-title":"Focused acoustic vortex-mediated sonochemotherapy for the amplification of immunogenic cell death combined with checkpoint blockade to potentiate cancer immunotherapy","volume":"301","author":"Ya","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.semcdb.2023.10.007_bib121","article-title":"Immunogenic PANoptosis-initiated cancer sono-immune reediting nanotherapy by iteratively boosting cancer immunity cycle","author":"Zhou","year":"2023","journal-title":"Adv. Mater."},{"issue":"24","key":"10.1016\/j.semcdb.2023.10.007_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301759","article-title":"Redox-responsive dendrimer nanogels enable ultrasound-enhanced chemoimmunotherapy of pancreatic cancer via endoplasmic reticulum stress amplification and macrophage polarization","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.semcdb.2023.10.007_bib123","doi-asserted-by":"crossref","first-page":"1167105","DOI":"10.3389\/fonc.2023.1167105","article-title":"Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib124","doi-asserted-by":"crossref","first-page":"2068109","DOI":"10.1080\/2162402X.2022.2068109","article-title":"Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade","volume":"11","author":"Kofla","year":"2022","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.semcdb.2023.10.007_bib125","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1008866","article-title":"Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy","volume":"4","author":"Pol","year":"2015","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41423-022-00956-0","article-title":"Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis","volume":"20","author":"Chen","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.semcdb.2023.10.007_bib127","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jitc-2023-006785","article-title":"Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib128","doi-asserted-by":"crossref","first-page":"1710398","DOI":"10.1080\/2162402X.2019.1710398","article-title":"ASTX660, an antagonist of cIAP1\/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer","volume":"9","author":"Ye","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2023.10.007_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101949","article-title":"Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer","volume":"42","author":"Freire Boullosa","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-021-00439-0","article-title":"The gold complex auranofin: new perspectives for cancer therapy","volume":"12","author":"Abdalbari","year":"2021","journal-title":"Discov. Oncol."},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib131","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtho.2020.01.015","article-title":"AXL targeting abrogates autophagic flux and induces immunogenic cell death in drug-resistant cancer cells","volume":"15","author":"Lotsberg","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.semcdb.2023.10.007_bib132","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1002\/ajh.26823","article-title":"Belantamab mafodotin induces immunogenic cell death within 24h post-administration in newly diagnosed multiple myeloma patients","volume":"98","author":"Kostopoulos","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib133","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1142\/S0192415X20500962","article-title":"Autophagy Impairment through Lysosome Dysfunction by Brucine Induces Immunogenic Cell Death (ICD)","volume":"48","author":"Ishimwe","year":"2020","journal-title":"Am. J. Chin. Med"},{"key":"10.1016\/j.semcdb.2023.10.007_bib134","article-title":"3,4-Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and T","author":"Chen","year":"2019","journal-title":"11(11)"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41420-020-00365-0","article-title":"Autophagy-mediated metabolic effects of aspirin","volume":"6","author":"Castoldi","year":"2020","journal-title":"Cell Death Discov."},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib136","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41419-020-03226-x","article-title":"Isobacachalcone induces autophagy and improves the outcome of immunogenic chemotherapy","volume":"11","author":"Wu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib137","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12192-013-0422-2","article-title":"Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells","volume":"18","author":"D'Eliseo","year":"2013","journal-title":"Cell Stress Chaperon-.-."},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib138","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3892\/etm.2016.3368","article-title":"Capsaicin induces immunogenic cell death in human osteosarcoma cells","volume":"12","author":"Jin","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib139","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nrd2682","article-title":"Novel therapeutic applications of cardiac glycosides","volume":"7","author":"Prassas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.semcdb.2023.10.007_bib140","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10637-013-9984-1","article-title":"Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials","volume":"31","author":"Slingerland","year":"2013","journal-title":"Investig. N. Drugs"},{"issue":"7","key":"10.1016\/j.semcdb.2023.10.007_bib141","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/0008-5472.CAN-21-3062","article-title":"CDK4\/6 inhibition suppresses p73 phosphorylation and activates DR5 to potentiate chemotherapy and immune checkpoint blockade","volume":"82","author":"Tong","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2023.10.007_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941757","article-title":"Chromomycin A(5) induces bona fide immunogenic cell death in melanoma","volume":"13","author":"Florencio","year":"2022","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202100656","article-title":"Enhancement of CD8(+) T-cell-mediated tumor immunotherapy via magnetic hyperthermia","volume":"17","author":"Zhang","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.semcdb.2023.10.007_bib144","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3389\/fonc.2019.01196","article-title":"Mitochondria-targeting immunogenic cell death inducer improves the adoptive t-cell therapy against solid tumor","volume":"9","author":"Jiang","year":"2019","journal-title":"Front Oncol."},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib145","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1016\/j.xphs.2022.06.005","article-title":"Ivermectin enhanced antitumor activity of resiquimod in a co-loaded squalene emulsion","volume":"111","author":"Zhang","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.semcdb.2023.10.007_bib146","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2015-02-630335","article-title":"Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma","volume":"126","author":"Rook","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib147","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/01635581.2021.1897632","article-title":"Immunogenic Cell Death (ICD) of Murine H22 Cells Induced by Lentinan","volume":"74","author":"Wang","year":"2022","journal-title":"Nutr. Cancer"},{"issue":"7","key":"10.1016\/j.semcdb.2023.10.007_bib148","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/mc.22811","article-title":"Treatment of colon cancer with liver X receptor agonists induces immunogenic cell death","volume":"57","author":"Wang","year":"2018","journal-title":"Mol. Carcinog."},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib149","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1656502","article-title":"Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity","volume":"8","author":"Xie","year":"2019","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib150","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/0008-5472.CAN-20-1441","article-title":"Enhanced antitumor immunity via endocrine therapy prevents mammary tumor relapse and increases immune checkpoint blockade sensitivity","volume":"81","author":"Sequeira","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2023.10.007_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102351","article-title":"Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma","volume":"54","author":"Xu","year":"2022","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.semcdb.2023.10.007_bib152","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.7150\/ijbs.70975","article-title":"A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway","volume":"18","author":"Wen","year":"2022","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.semcdb.2023.10.007_bib153","first-page":"7","article-title":"Norcantharidin induces immunogenic cell death of bladder cancer cells through promoting autophagy in acidic culture","volume":"23","author":"Xu","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib154","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/s41388-021-01687-8","article-title":"Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis","volume":"40","author":"Fletcher","year":"2021","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib155","first-page":"1514","article-title":"Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells","volume":"8","author":"Ye","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.semcdb.2023.10.007_bib156","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3389\/fonc.2019.00436","article-title":"STAT3 contributes to oncolytic newcastle disease virus-induced immunogenic cell death in melanoma cells","volume":"9","author":"Shao","year":"2019","journal-title":"Front Oncol."},{"issue":"3","key":"10.1016\/j.semcdb.2023.10.007_bib157","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10799893.2019.1655050","article-title":"Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma","volume":"39","author":"Sun","year":"2019","journal-title":"J. Recept Signal Transduct. Res"},{"issue":"4","key":"10.1016\/j.semcdb.2023.10.007_bib158","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"29","author":"Tesniere","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2023.10.007_bib159","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.oraloncology.2019.06.016","article-title":"Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer","volume":"95","author":"Park","year":"2019","journal-title":"Oral. Oncol."},{"key":"10.1016\/j.semcdb.2023.10.007_bib160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jitc-2020-001714","article-title":"Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer","volume":"8","author":"Arai","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"11\u201312","key":"10.1016\/j.semcdb.2023.10.007_bib161","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10495-020-01643-z","article-title":"The delay in cell death caused by the induction of autophagy by P2Et extract is essential for the generation of immunogenic signals in melanoma cells","volume":"25","author":"Prieto","year":"2020","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib162","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.134","article-title":"Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model","volume":"7","author":"Gomez-Cadena","year":"2016","journal-title":"Cell Death Dis."},{"issue":"18 Pt 1","key":"10.1016\/j.semcdb.2023.10.007_bib163","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1158\/1078-0432.CCR-07-0517","article-title":"Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth","volume":"13","author":"Zhong","year":"2007","journal-title":"Clin. Cancer Res"},{"issue":"3","key":"10.1016\/j.semcdb.2023.10.007_bib164","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00280-020-04209-7","article-title":"Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8(+) T cell augmentation","volume":"87","author":"Shan","year":"2021","journal-title":"Cancer Chemother. Pharm."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/cas.13885","article-title":"CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells","volume":"110","author":"Uscanga-Palomeque","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcdb.2023.10.007_bib166","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/cells9041033","article-title":"Insights into P-glycoprotein inhibitors: new inducers of immunogenic cell death","volume":"9","author":"Kopecka","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.semcdb.2023.10.007_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101430","article-title":"Phase I study of PT-112, a novel pyrophosphate-platinum immunogenic cell death inducer, in advanced solid tumours","volume":"49","author":"Karp","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"16","key":"10.1016\/j.semcdb.2023.10.007_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163851","article-title":"PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial Deficiencies","volume":"14","author":"Soler-Agesta","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.semcdb.2023.10.007_bib169","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1039\/d0mt00227e","article-title":"Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids","volume":"12","author":"Wernitznig","year":"2020","journal-title":"Metallomics"},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib170","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051314","article-title":"Rafoxanide induces immunogenic death of colorectal cancer cells","volume":"12","author":"Di Grazia","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib171","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00262-012-1258-9","article-title":"Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine","volume":"61","author":"Chen","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib172","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/s41467-021-23752-2","article-title":"Targeted PI3K\/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia","volume":"12","author":"Ecker","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcdb.2023.10.007_bib173","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2020.09.011","article-title":"CDK12\/13 inhibition induces immunogenic cell death and enhances anti-PD-1 anticancer activity in breast cancer","volume":"495","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.semcdb.2023.10.007_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10110470","article-title":"SS1P immunotoxin induces markers of immunogenic cell death and enhances the effect of the CTLA-4 BLOCKADe in AE17M mouse mesothelioma tumors","volume":"10","author":"Leshem","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.semcdb.2023.10.007_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jitc-2019-000462","article-title":"Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy","volume":"8","author":"Wang","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081954","article-title":"A novel thienopyrimidine analog, TPH104, mediates immunogenic cell death in triple-negative breast cancer cells","volume":"13","author":"Tukaramrao","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.semcdb.2023.10.007_bib177","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41419-020-2304-8","article-title":"Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia","volume":"11","author":"Song","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib178","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2016.05.016","article-title":"Caloric restriction mimetics enhance anticancer immunosurveillance","volume":"30","author":"Pietrocola","year":"2016","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.semcdb.2023.10.007_bib179","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1080\/15548627.2016.1214778","article-title":"Autophagy induction for the treatment of cancer","volume":"12","author":"Pietrocola","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.semcdb.2023.10.007_bib180","article-title":"Autophagy activation by dietary piceatannol enhances the efficacy of immunogenic chemotherapy","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.semcdb.2023.10.007_bib181","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1080\/15548627.2020.1758417","article-title":"Autophagy induction by thiostrepton for the improvement of anticancer therapy","volume":"16","author":"Kepp","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.semcdb.2023.10.007_bib182","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12943-015-0435-9","article-title":"Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components","volume":"14","author":"Lin","year":"2015","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib183","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41419-021-03997-x","article-title":"Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects","volume":"12","author":"Petrazzuolo","year":"2021","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.semcdb.2023.10.007_bib184","doi-asserted-by":"crossref","first-page":"15471","DOI":"10.1021\/acsnano.2c08013","article-title":"Immunogenic cell death augmented by manganese zinc sulfide nanoparticles for metastatic melanoma immunotherapy","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.semcdb.2023.10.007_bib185","article-title":"Immunogenic cell death (ICD) enhancers-Drugs that enhance the perception of ICD by dendritic cells","author":"Liu","year":"2023","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib186","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7164\/antibiotics.25.271","article-title":"A new antibiotic, ikarugamycin","volume":"25","author":"Jomon","year":"1972","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib187","doi-asserted-by":"crossref","first-page":"2242211","DOI":"10.1080\/2162402X.2023.2242211","article-title":"Histamine antagonists promote cancer immunosurveillance","volume":"12","author":"Liu","year":"2023","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib188","doi-asserted-by":"crossref","first-page":"2271693","DOI":"10.1080\/2162402X.2023.2271693","article-title":"A mitochondrial checkpoint to adaptive anticancer immunity","volume":"12","author":"Kepp","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcdb.2023.10.007_bib189","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-22-1338","article-title":"BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance","author":"Zhao","year":"2023","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-019-0064-5","article-title":"Radiotherapy toxicity","volume":"5","author":"De Ruysscher","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"8","key":"10.1016\/j.semcdb.2023.10.007_bib191","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.semcdb.2023.10.007_bib192","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrcardio.2016.39","article-title":"Cardioprotection: cardiotoxicity of anticancer therapy","volume":"13","author":"Fernandez-Ruiz","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.semcdb.2023.10.007_bib193","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41574-021-00484-3","article-title":"Endocrine toxicities of immune checkpoint inhibitors","volume":"17","author":"Wright","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib194","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Ramos-Casals","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"7","key":"10.1016\/j.semcdb.2023.10.007_bib195","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1177692","article-title":"Calreticulin expression: interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer","volume":"5","author":"Stoll","year":"2016","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.semcdb.2023.10.007_bib196","doi-asserted-by":"crossref","first-page":"2093518","DOI":"10.1080\/2162402X.2022.2093518","article-title":"PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.semcdb.2023.10.007_bib197","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1007\/s00262-023-03470-y","article-title":"Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer","volume":"72","author":"Egelston","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.semcdb.2023.10.007_bib198","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1470-2045(20)30068-1","article-title":"Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial","volume":"21","author":"Trigo","year":"2020","journal-title":"Lancet Oncol."},{"issue":"26","key":"10.1016\/j.semcdb.2023.10.007_bib199","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2016-08-731737","article-title":"Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients","volume":"128","author":"Fucikova","year":"2016","journal-title":"Blood"}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952123002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952123002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:21:15Z","timestamp":1761067275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952123002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":199,"alternative-id":["S1084952123002045"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2023.10.007","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenic cell stress and death in the treatment of cancer","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2023.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}